We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Amgen creates biosimilars – medicines that are similar in structure to an original ‘reference product’.|It is vital that a biosimilar has no differences from the reference product that would cause issues in terms of safety or effectiveness.
RBM can support and enhance practices that are designed to ensure patient safety.|A centralised approach requires a steady, reliable flow of data from each study site to the central monitoring system, through either manually entered and transferred data, or an automated connection between the data entry system and central dashboard.
The biopharmaceutical industry is trying to harness potential digital connectivity.|Technology will need to evolve in step with increasing amounts of data and this, in turn, will require that those using it will need a thorough understanding of how to analyse the reams of new information in order to put it to best use.
In a climate of dwindling budgets and increasingly complex technology, a well-organised trial stands the best chance of being a successful one.
Packaging can influence patients’ attitudes to the treatments they receive in trials.|A primary goal of blinding should be to limit the likelihood of patents being able to differentiate between products based on appearance.
Combining EHRs with other metrics gives researchers a detailed picture of a patient’s health.|The proliferation of new databases and a decentralised recruitment system means that researchers must be careful to balance RWD’s power with patient confidentiality.
As part of its Clinical Trial Transparency initiative, the European Medicines Agency (EMA) mandated a requirement for clinical trial sponsors to prepare a summary of the results of
Programmes like the Dubai Fitness Challenge encourage people to be more active on a daily basis. This is a positive change, but more can be done – especially in the healthcare sector.|Misdiagnosis could be attributed to the belief that obesity is a lifestyle choice. In fact, air pollution, using plastic and many other extraneous factors are related to weight gain.
It is hoped that MD Anderson’s discovery of Non-V600 BRAF mutations will help to tailor treatments for cancer patients, particularly those that have negative effects, such as chemotherapy.
Sayed (far left) was a speaker at the Free C Child symposium, which was supported by the Egyptian Liver Care Society (ELSC), a non-governmental organisation.|Members of the ELSC, which include famous actress Yousra (third from the left) and chair Yousriya Loza-Sawiris (second from the left). Sayed is third from the right.